US2007228124A1PendingUtilityA1

Folding boxes

Assignee: BAXTER HEALTHCARE SAPriority: Apr 3, 2006Filed: Jul 25, 2006Published: Oct 4, 2007
Est. expiryApr 3, 2026(expired)· nominal 20-yr term from priority
B65D 5/5495B65D 5/0254
34
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a folding box and to a set of drugs having a folding box. The folding box of the invention is easy to produce, easy to handle, and allows the set of components to be kept separate from one another.

Claims

exact text as granted — not AI-modified
1 . A folding box that has a first container part (B 1 ) and a second container part (B 2 ), the first container part having first container walls and the second container part having second container walls, the first container walls forming a first container interior (I 1 ) and the second container walls forming a second container interior (I 2 ) physically separated from the first container interior, and the first container part being releasably connected to the second container part by means of a connecting element ( 100 ). 
   
   
       2 . The folding box as claimed in  claim 1 , wherein at least a first side wall (S 1 ) of the first container walls and a second side wall (S 2 ) of the second container walls are formed from a single-piece wall (W) and the connecting element ( 100 ) is formed from a perforation of the single-piece wall (W). 
   
   
       3 . The folding box as claimed in one of the preceding claims, wherein a layout of the folding box is essentially formed from a continuous single-piece wall (W) perforated along the connecting element. 
   
   
       4 . The folding box as claimed in one of the preceding claims, wherein the perforation of the connecting element ( 100 ) runs along a straight line in the layout. 
   
   
       5 . The folding box as claimed in one of the preceding claims, wherein the perforation of the connecting element is formed, when the folding box is folded, from at least two areas ( 110 ,  120 ;  120 ,  130 ;  120 ,  140 ) that do not run along a straight line. 
   
   
       6 . The folding box as claimed in  claim 5 , wherein the at least two areas ( 110 ,  120 ;  120 ,  130 ;  120 ,  140 ) run at least in each case partly along two shared edges of the first container part and the second container part. 
   
   
       7 . The folding box as claimed in  claim 6 , wherein the two edges are perpendicular to one another. 
   
   
       8 . The folding box as claimed in one of the preceding claims, wherein, when the two container parts (B 1 , B 2 ) are not separated, the connecting element ( 100 ) runs in each case at least partly along three shared edges of the first container part (B 1 ) and of the second container part (B 2 ). 
   
   
       9 . The folding box as claimed in one of the preceding claims, wherein, when the two container parts (B 1 , B 2 ) are not separated, the connecting element ( 100 ) runs in each case at least partly along four shared edges of the first container part (B 1 ) and of the second container part (B 2 ). 
   
   
       10 . The folding box as claimed in one of the preceding claims, wherein, when the folding box is folded together but not separated, a ninth side wall (S 9 ) and a tenth side wall (S 10 ) come to rest at least partly against one another and at least one of the side walls in this area where they rest against one another has a printed area. 
   
   
       11 . The folding box as claimed in  claim 10 , wherein the printed area is prepared so that information can be added to it by hand, in particular references to certain dates, which are to be entered by hand in areas provided for this purpose. 
   
   
       12 . A set of drugs that has a first set component, a second set component and a folding box as claimed in one of  claims 1  to  11 , the first set component being kept in the first container interior (B 1 ) and the second set component being kept in the second container interior (B 2 ). 
   
   
       13 . The set of drugs as claimed in  claim 12 , wherein the first set component is designed so that the shelf life of the first set component is extended by cooling to below room temperature, preferably in a temperature range between about 0° C. and 10° C. 
   
   
       14 . The set of drugs as claimed in  claim 12  or  13 , wherein the second set component is designed so that cooling of the second set component does not significantly improve its shelf life.

Join the waitlist — get patent alerts

Track US2007228124A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.